ABSTRACT The evidence relating the interferon system to the infectious process has been examined. The available evidence supports the view that the interferon system is an important component of the body's nonimmune defenses, which are probably the major causes of recovery from already established virus infections of body tissues. The interferon system can also serve to limit virus spread through the bloodstream. Factors which may influence the interferon system and thereby influence virus infection have been considered. Finally, evidence is presented which indicates that the interferon system is one of the determinants of virulence of certain viruses and is one of the determinants of some persistent virus infections.
Production of interferon by the infected cell is thought to be preceded by derepression of the interferon cistron, leading to formation of interferon messenger RNA which then results in production of interferon protein. Completed interferon is rapidly released by cells. Production of the proposed antiviral substance, after reaction of cells with interferon, is similarly thought to be preceded by derepression of another cistron and formation of messenger RNA which is then translated into a polypeptide. There is little evidence to help determine whether the polypeptide is itself the antiviral substance in the resistant cell, or whether it controls formation of an antiviral substance. Fig. 1 summarizes these interactions.
The interferon system is the earliest appearing of the known host defenses in that it can be detected to be operative within hours after infection (3) . Most viruses are able to induce interferon to a greater or lesser extent, and most viruses are sensitive to its antiviral action also to a greater or lesser extent. The antiviral action of interferon is intracellular and may relate to an inhibition of the functioning of the viral messenger RNA with the cells ribosomes. The duration of activation of the interferon system (interference) is from 1 to 3 wk during acute virus infections in vivo (11) (12) (13) . The concepts of the sequential formation of the components of the interferon system are presented so they may serve as the basis for some of the subsequent interpretations.
ROLE OF INTERFERON DURING ESTABLISHMENT OF VIRAL INFECTION AT THE IMPLANTATION SITE
Successful infection at the implantation site requires that viruses replicate in the initially infected cell and then spread to infect other cells within the same tissue. The first host defense to make its appearance is the interferon system (2, 3) . It is produced by infected cells at about the same time as virus is proproduced. Replication of virus in the initially infected cell is probably not VIRUS a._a_ I94 s~ affected by the interferon system. The interferon mechanism which is activated within the infected cell probably does not inhibit virus infection within that cell. This comes from the finding that inhibition of interferon production by metabolic inhibitors in virus-infected cells does not significantly increase the virus yield during a one-step growth cycle (14) .
The interferon protein is released from infected cells as it is produced and diffuses to surrounding cells where it activates the production of the antiviral state. In this way spreading virus meets an intracellular barrier to its continued replication. The degree of antiviral activity is probably dependent on the extracellular concentration of interferon (15) , so the cells in closest contact with the infected, interferon-producing cells become most resistant to virus. Protection of more distant cells does occur but to a lesser degree (16, 17) . The interferon defense functions in this manner not only in infected tissues at the portal of entry, but in any infected tissue as considered below.
Successful establishment of viral infection at the implantation site sometimes leads to disease in that same tissue (e.g., influenza infection of the lung, rhinovirus infection of the nasal tract, and wart virus infection of the skin). For other viruses the established infection at the portal of entry serves as a dissemination site for spread to other organs and tissues where the disease symptoms originate.
ROLE OF INTERFERON DURING SPREAD OF VIRUS TO DISTAL TISSUES AND ORGANS
Virus may spread from the portal of entry to target organs by means of body fluid (serum or lymph) or by means of infected cells. Interferon appears in serum within a few hours after the onset of viremia (17) . Experiments utilizing passive transfer of interferon indicate that the circulating interferon can act to both reduce the viremia and to reach target organs where it protects cells against subsequent seeding of virus from the bloodstream and lymph (17) (18) (19) .
Spread of virus may also occur via infected cells such as those in nerves and via white blood cells. Spread of infection along a nerve has not been studied in terms of the interferon defense. However the possible role of the interferon mechanism may be surmised from other knowledge. Spread of virus along the sheath surrounding the axon would be expected to be resisted in the same way as is virus spread during early infection of any tissues (see above). Spread of virus within a nerve axon could be retarded only by intracellularly active defense mechanisms. The interferon defense might be less effective in this situation because activation of the interferon system would be delayed until virus or interferon reaches the distant nucleus of the nerve cell to derepress the cistron encoded for antiviral protein.
Virus may also spread by infected white blood cells, which, due to their mobility, could deposit infectious virus in target organs. Several of the host defenses have been shown to affect the ability of leukocytes to support virus growth. The lymphoid series of cells in the body are particularly sensitive to the induction of interferon in that a broad range of viral and nonviral stimuli can induce these cells. The ready response of interferon production has also provided the first known bridge between the immunological system and the interferon system and will be considered in the section by Dr. L. Glasgow.
ROLE OF INTERFERON DURING RECOVERY FROM

THE FULLY ESTABLISHED VIRUS INFECTION OF
BODY TISSUES AND ORGANS
Virus may establish an infection in various tissues within the body including the implantation site, tissues in contact with the vascular system, and target organs. It seems probable that the mechanisms which govern the recovery from the fully infected tissue apply at these diverse sites of established infection. The recovery process may not occur simultaneously within the various infected tissues in the body because the time of onset of infection and time of production of localized host defenses is usually different for the different tissues. In this way, tissues at the implantation site or tissues in contact with the vascular system may be undergoing recovery at the time that virus infection is being established within the target organs (20) (21) (22) .
The finding that a major characteristic of the recovering tissue is nonspecific resistance to viral superinfection indicates that nonimmune defenses like interferon are correlated temperally with recovery from the established infection. Fig. 2 schematizes the relative occurrences of virus growth, disease, interferon, and antibody during the first and during a repeat infection. Supporting evidence comes from many sources.
A sufficient quantity of interferon can inhibit the multiplication of most viruses in various animal tissues in vivo and in vitro (3) . Interferon is generally present in infected tissues of animals prior to the onset of recovery from diverse virus infections (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . Similar results have been obtained in studies in man (8, 34) . These studies have demonstrated that interferon can be produced as early as 1 hr after virus infection and is generally demonstrable in high titer within 1-2 days. In comparison, recovery, as measured by decreasing virus in the infected tissue, usually begins 1 or more days after interferon is first detected. The presence of interferon in target organs during recovery is evidenced by these same studies and also by others (35) (36) (37) . Apparently, inconsistent findings are the low or undetectable levels of interferon in organs of mice during certain nonlethal infections (38) (39) (40) (41) (42) (43) . But some of these viruses may have been very sensitive to interferon. Hence, interferon produced by cells originally infected may have so reduced virus multiplication that little or no detectable amounts of interferon were formed (44) . The finding that tissues of mice which were chronically infected with lymphocytic choriomeningitis virus manifested interference in the absence of detectable interferon (38) suggests either the possibility of another antiviral factor, or that the antiviral portion of the interferon system may have been functioning despite the absence of detectable interferon as discussed above.
Further evidence relating the interferon system to recovery comes from the expectation that decreased function of the interferon mechanism would increase the severity of those virus infections in which it contributes significantly towards recovery. Such were the findings in young chick embryos with an "immature" interferon system (45) . More recent studies have extended the evidence. Decreased function of the interferon system, as caused by altered temperature, psychological stress, chemical inhibitors, and different virus strains, led to impaired recovery of animals (30, (46) (47) (48) (49) . Carefully controlled studies of tissue cultures infected with vaccinia, herpes, measles, or arboviruses also indicate that impairment of the interferon mechanism hinders recovery (50) (51) (52) (53) (54) .
The effect of specific decrease in the functioning of the interferon mechanism is clearly demonstrated in studies of arbo B virus infection of two strains of C3H mice (44) . C3H and C3H RV mice are known to differ only at the genetic locus which determines resistance to infections with arbo B viruses. They produce equal amounts of interferon after arbo B virus infection, but the virus-resistant C3H RV cell cultures and the intact mice were much more sensitive to the inhibitory effect of interferon when tested with arbo B viruses than were the C3H cultures or mice. The increased effectiveness of interferon was limited to arbo B viruses. Thus a genetic difference in interferon responsiveness determined the severity of virus infection both in tissue culture and in the intact mouse. This study also points out the problem in interpreting the role of interferon only from interferon production findings (55), since cell responsiveness to interferon can also be a determining factor.
Another test of the relationship of the interferon system to recovery is the transfer of presently available amounts of interferon to animals. These early studies demonstrated greatest protection when interferon was given prior to or at the same time as infection and not when interferon was given significantly after infection (56) (57) (58) (59) (60) (61) (62) (63) . More recently treatment with large amounts of interferon or inducers of interferon was shown to retard the development of estab-lished infections with encephalomyocarditis virus, leukemia virus, herpes simplex virus, and other viruses. Analogously, production of interferon by virus-resistant cells in a mixed tissue culture can protect the virus-susceptible fraction of the cell population (64) . The failure of interferon to protect man against subsequent rhinovirus infection (65), unlike the previously reported protection against subsequent vaccinia virus infection (59) , may have been due to dosage problems.
Taken together most of the available evidence does support a causal relationship between the interferon system and recovery from established infections. The available evidence also indicates that interferon is not the sole factor which influences recovery, and in certain virus infections it may not be the most important factor (10).
INTERPLAY OF INTERFERON WITH OTHER FACTORS DURING INFECTION
The possibility has been raised that nonimmune antiviral factors may affect the interferon system as well as directly inhibit virus multiplication (66) . Certain ones will be briefly considered here in relation to recovery from virus infection. For example, lowered or raised temperature may respectively depress or enhance the interferon system during infections in vitro and in vivo (47, 53, 66, 67) . Changes in pH and oxygen tension have been reported to enhance or retard production of the interferon system in certain, but not all, virus infections in vitro (68) (69) (70) (71) (72) .
Other mechanisms may also affect the interferon system. Corticosteroids have been reported to inhibit the interferon system in several, but not all, virus infections in ovo and in vitro (73) (74) (75) . The effect of psychological stress on inhibiting production of interferon and increasing the severity of vesicular stomatitis virus and polyoma virus infections of mice may have a hormonal basis (48) .
It has been observed that cells and animals which have yielded interferon may not yield again for a period of time on restimulation by virus (76) (77) (78) (79) . Hyporeactivity to release of interferon by endotoxin may be due to a circulating inhibitor of endotoxin in the rabbit (77, 80) . The significance or hyporeactivity during virus infection is yet to be determined.
Another factor which has been reported to influence the interferon system is the age of the animal. Tissues from young chick and mouse embryos were generally found to have a poorly functioning interferon system (45, (81) (82) (83) , and this system has been shown in mice to continue to develop through the neonatal period (84) (85) . Several of these investigators have suggested that lack of effectiveness of the immature interferon system may be one factor which contributes to the malforming effects of some virus infections of the fetus and to unusually severe infections during the neonatal period (7) . In-consistent is the finding that lymphocytes from young human embryos have been found to produce normal amounts of interferon (K. Cantell and H. Strander, 1969, personal communication.) .
Results of several studies have indicated that pretreatment of cells with interferon influences the subsequent production of interferon by infected cells (86) (87) (88) . Chicken and mouse cells treated with small amounts of interferon and then infected with virus produce substantially more interferon than do cells not previously treated with interferon. Pretreatment with large amounts of interferon has the reverse effect of decreasing subsequent production of interferon. It was also observed that chicken cells pretreated with small amounts of interferon not only produced increased amounts of interferon after infection, but they produced interferon and its messenger RNA substantially earlier than cultures which had not been pretreated (89, 90) . Such an enhanced response bears a superficial resemblance to an immunological booster effect and may similarly act to amplify the interferon defense mechanism.
Some viruses may inhibit the interferon system by causing a general depression of the cellular RNA or protein synthesis which seems to be required for production of both interferon and the proposed antiviral substance. For example, mengo virus has been reported to produce two distinct proteins which respectively inhibit cellular synthesis of RNA and protein (91) . Similar inhibition of cellular RNA synthesis following infection of cells by herpes simplex and vesicular stomatitis viruses has been correlated with decreased production of interferon (92, 93) . Inhibition of the interferon system before production of the antiviral substance could act to prevent the action of this antiviral mechanism. However, prior establishment of the antiviral effect has been reported to retard the virus-induced inhibition of cellular synthesis of RNA (94, 95) . The significance of these phenomena in relation to virulence of viruses and pathogenesis of infection deserves further study. It also raises the possibility that infection of an animal by a virus which inhibits synthesis of components of the interferon system could increase the severity of a subsequent infection by another virus.
A natural experiment which illustrated an interplay of these host defense factors is the human disease syndrome hypogammaglobulinemia (see reference 7). Impairment of production of normal amounts of antibody by these patients is believed to result in increased frequency and severity of certain pyogenic bacterial infections as well as a lesser increase in severity of certain virus infections. The small amount of antibody produced by these patients is sufficient to account for a resistance to the spread of many viruses through the bloodstream and, therefore, can account for the immunologically specific resistance to reinfection observed in these patients. Since the nonimmune and nonspecific defense factors are largely independent of the immune response, the ability of hypogammaglobulinemic patients to recover normally from established virus infection is probably due to normally functioning cellular immunity (see reference 7), interferon (96) , body temperature control, inflammatory responses, etc. The occasionally observed increased severity of virus infections in these patients (e.g. vaccinia virus and poliomyelitis infections) might be explained by impaired antibody production during the viremic spread of virus in the primary infection with resulting prolonged viremia and increased seeding of target organs.
THE INTERFERON SYSTEM AS A FACTOR IN THE VIRULENCE OF VIRUSES
If the interferon system plays an important role in the body's defense against virus infection, then it should be an important determinant of virus virulence (97) . A virulent virus will be considered as one which causes relatively more damage to the infected host system than do other strains of the same virus type.
The definition of virus sensitivity to the antiviral action of interferon becomes critical in any comparison with virulence of viruses. Certain viruses like adenoviruses (98, 99) , herpes viruses, including cytomegaloviruses (100, 101), have been considered to be relatively resistant to the antiviral action of interferon. It recently has been found however that cell-free human cytomegalovirus is highly sensitive to the antiviral action of human interferon (D. Lang, M. T. Thomas, and I. Gresser, 1969, personal communication). Similarly, in the mouse, it has been found that induction of interferon protects against very small challenge doses of herpes simplex virus as well as it does against small or large doses of the highly sensitive encephalomyocarditis virus. However, there is no protection against moderate to high doses of herpes virus (102) . These findings indicate that under certain experimental conditions cytomegalovirus and herpes simplex virus may be highly sensitive to the antiviral action of interferon. It has been suggested that the production of anti-interferon factors (D. Lang, M. T. Thomas, and I. Gresser, 1969, personal communication; 103, 104) (see below) could account for the difference in sensitivity under different experimental conditions. A highly virulent virus should not be significantly inhibited by any natural defense factors (including the interferon system) which are active during infection, and/or the virulent virus should not elicit these defensive responses. Consistent with this interpretation are the observations that the interferon system is relatively ineffective in infections with more virulent strains of certain viruses, and conversely, the interferon system is often more effective during infections with less virulent viruses. Supporting data have been obtained with strains of Newcastle disease virus (67, 105) (44, 67) , foot-and-mouth disease virus (109) , and polyoma virus (30) .
It has recently been found that virulent strains of Newcastle disease virus induce little interferon during infection of chickens, but that avirulent strains induce larger amounts of interferon during infection and at the same time manifest a resistance to superinfection with Newcastle disease virus (110) .
As might be anticipated from the existence of a large number of virus inhibitory factors in addition to the interferon system (111-113), there is not always such a correlation between the response of the interferon system and virulence, e.g., with strains of influenza virus (40, 42) , Sindbis virus (39), Newcastle disease virus (105) , and vaccinia virus (41) . These reports are consistent with multiple determinants of virus virulence.
Taken together, the findings are consistent with the interpretation that the interferon system may be an important determinant of relative virulence of certain virus strains. However, definitive studies must await development of techniques for the simultaneous measurement of yield of virus, interferon, and antiviral activity per infected cell, in vitro and at different stages of infection in the intact animal.
Recent observations indicate two additional mechanisms whereby a virus may avoid the inhibitory effect of the interferon system and, perhaps, thereby manifest increased virulence. First, conditions of infection by herpes simplex virus (92) and vesicular stomatitis virus (93) , which lead to inhibition of cellular RNA synthesis, suppress the synthesis of components of the interferon system while enhancing yields of virus. The phenomenon of "inverse interference" (114) may have a similar basis. That inhibition of cellular RNA synthesis is not the sole means by which virus may cause decreased production of interferon is suggested by the findings that avirulent strains of Newcastle disease virus and parainfluenza type 3 virus failed to induce interferon production in cells, although no cytopathology occurred (105, 115, 116) . Absence of cytopathology suggests that there was no significant inhibition of RNA synthesis during the growth of these viruses. Mouse leukemia virus and mouse cytomegalovirus infections are other examples (117, 118) . These findings indicate that certain cell-virus interactions do not lead to production of much interferon, as a result either of inhibition by virus of cellular synthetic processes or of unknown mechanisms. The relationship between ability of virus to inhibit the response of the interferon system and virulence merits further study.
A second mechanism whereby virus may overcome the inhibitory effect of the interferon system is the reported existence of a fraction of virus populations which is resistant (104, 119). It was observed that a fraction of an encephalomyocarditis virus population, varying from 10 to 15% of the input virus, was capable of multiplying in interferon-treated mouse embryo cultures (104). The resistance of this "persistent fraction" to interferon was not due to a genetic property of the virus, and superficially it resembled similar phenomena observed with most other virus-inactivating agents (120) . Vesicular stomatitis virus and vaccinia virus were also shown to contain interferonresistant persistent fractions. The magnitude of the persistent fraction may vary depending on the virus, type of cell, as well as on the cellular environment. A large persistent fraction of this type could exert an important influence on virulence of infection, but such studies are yet to be carried out in vivo.
ROLE OF THE INTERFERON SYSTEM IN PERSISTENT
INFECTIONS
Persistent infection in vitro and in vivo may result from infection of genetically resistant cells, from antibody or other virus inhibitors in extracellular fluids, from interference and interferon, and from unknown factors (121) . Several persistent infections of tissue cultures are thought to be caused by the interferon system, although only a few definitive studies have been reported. Interferon has been detected at very early and at advanced stages of persistent infection of mouse L cells with Newcastle disease virus (122) (123) (124) , human amnion and KB cells with poliovirus (125) , calf kidney cells with the WS strain of influenza virus and with foot-and-mouth disease virus (126, 127) , KB cells with parainfluenza type 3 virus (128), mouse embryo cells with vaccinia virus (50) , human amnion and mouse L cells with tick-borne encephalitis virus (53, 129) , mouse 23 P cells with polyoma virus and with herpes simplex virus (90) , and monkey cells with rubella virus (130) . Similar results have been observed during the early period of infection of mice with lactic dehydrogenase virus (32) . Interferon was found during the later stages of persistent infection of mouse cell cultures with polyoma viruses; tests for it were not made during the early stages (131) . Neither interferon nor significant interference of the interferon type was detected in mouse L-cell cultures persistently infected with polyoma virus (123, 132) , in chicken cells infected with RAV leukosis virus (133) , or in mouse cells infected with murine leukemia viruses (134) , suggesting that the interferon system did not participate in the maintenance of these carrier cultures. Persistent infections of mice or of mouse L-cell cultures with lymphocytic choriomeningitis virus did not give rise to detectable interferon but did result in interference (38) . However, the precise times of sampling of these persistently infected mice were not stated, and it is possible that interferon was produced during the initial stages of infection as it is during infection with lactic dehydrogenase virus. The demonstration of interference when no or only low levels of interferon can be detected does not exclude an important role for the interferon system during these persistent infections. It is conceivable that (a.) the rapid turnover rate of interferon in vivo (17, 19, 135) reduces levels below detectability, or (b) intracellular inter-202 S feron in amounts which cannot be detected may still be highly effective (53, 136) .
Further evidence linking the interferon system to persistent infections comes from studies of inhibition or enhancement of the interferon system during persistent infections. Enhancement of the interferon mechanism retarded multiplication of vaccinia virus, herpes simplex virus, and tick-borne encephalitis virus during persistent infections in mouse cell cultures (50, 53, 88) . Similarly in mice, stimulation of the interferon system inhibited the growth of lactic dehydrogenase virus (137) . Conversely, inhibition of the interferon mechanism by several techniques was followed by enhanced virus growth and increased cell destruction in persistently infected mouse cell cultures (50, 53, 88) . In general, the resistance of persistently infected cultures was nonspecific for virus-a property coinciding with that of the interferon system. The quantity of interferon was shown to be sufficient to account for the observed inhibition of herpes simplex virus during persistent infection of mouse cell cultures with both herpes simplex and polyoma viruses (88) . Studies with other viruses and cells are needed to establish that the antiviral activity of the interferon system is quantitatively sufficient to account for persistent infections. Another difficulty is that certain persistently infected cell cultures which manifest interference produce interferon but are not sensitive to the action of exogenous interferon (53, 125, 128, 129) . It is possible that the interferon produced within the infected cells is better able to induce the antiviral state than is exogenous interferon.
Several of these investigators and others (138) have suggested that those persistent infections which are dependent upon the interferon system may result from a shifting balance between antiviral activity and virus multiplication. Specifically, increasing multiplication of virus in a persistently infected system induces increased production of interferon and antiviral activity, which prevents further increase of virus. Conversely, decreasing multiplication of virus results in decreased interferon and antiviral activity, which then permits increase of virus multiplication.
That the interferon system may be participating in naturally occurring persistent infections comes from several studies. Interferon was produced by cultured cells from three different cases of human malignant lymphoma (139, 140) . Herpes simplex virus-like particles are frequently found in these cells by electron microscopy (141) . Another example is the observation that cultures from normal chick embryos can initiate production of interferon (R. Z. Lockart, Jr., and T. Sreevalsan, 1965, personal communication). Since many flocks of chickens are persistently infected with leukosis viruses (142) and perhaps other viruses, it is possible that the interferon production resulted from a persistent infection in ovo.
Taken together, the available evidence favors the view that the interferon system is an important determinant of certain persistent infections in vitro and in vivo. However, further studies are needed to determine what proportion of persistent infections it influences.
APPLICATION TO CONTROL OF VIRAL DISEASE
Medical science has very effectively adapted the natural antibody defense against viral spread and reinfection to prevent but not to treat viral infections. The natural antibody defense is nontoxic, and so application has been achieved with minor problems of toxicity. Antibody has been applied to disease prophylaxis both by passive transfer of antibody and by vaccine stimulation of antibody. However, a major limitation of the application of the antibody defense is a lack of effectiveness of antiviral antibody after the establishment of infection of the target organs. A classic example is the ability of antibody to prevent measles infection of children when the antibody is given early after exposure to virus, but as the incubation period of measles progresses the amount of antibody required to influence the oncoming disease increases rapidly. Towards the end of the incubation period of measles no amount of antibody provides protection. Thus antibody against measles virus loses its effectiveness as the onset of the established disease approaches. By analogy it had been predicted that the interferon defense system which is thought to naturally promote recovery could be applied to both prevent and treat virus infection (c.f. 2, 3, 7, 9, [143] [144] [145] . Also, as a natural defense mechanism, toxicity should be minimal. It has already been demonstrated that interferon can prevent a broad range of virus infections. However, until recently the limitation of the quantity of interferon which could be produced and the species barrier to the action of interferon have prevented therapy of established infections (145) . These limitations have also prevented practical prophylaxis of viral infections of man. As a result many studies have concentrated on the development of chemicals which induce the body to produce large amounts of its own interferon. Beginning with Isaacs and his coworkers (68) , it has been shown that such inducers can be found and that some of them are relatively nontoxic and inexpensive. These inducers include extracts of microorganisms, such as statolon (146) . Also included are the synthetic pyran copolymers (147) and natural and synthetic ribonucleic acids (148, 149) . Certain of the RNA inducers of the interferon mechanism are extremely potent. The therapeutic efficacy of RNA inducers of interferon in herpes keratoconjunctivitis has been studied (150) (Fig. 3) . Fig. 3 shows that rabbits with herpes infections of the eye may be treated with interferon inducers after establishment of the disease with resulting enhanced recovery from the infection.
Quite recently it has been found that inducers of interferon will protect against certain protozoal parasites (151) (152) (153) . This aspect will be considered in this session by Dr. Jahiel. It has been reported that the interferon inducer, polyinosinic: polycytidylic acid (154) inhibits the growth of a number of experimental tumors in animals. Most of the tumor types were not deliberately induced by virus, but rather, they were transplanted tumors of spontaneous origin or induced by chemical carcinogenesis (154) (155) (156) (157) (158) . This compound, in addition to inducing interferon, enhances cell mediated graft vs. host reactions and may have direct specific chemotherapeutic action against some of the tumors. It is not yet clear how much of the antitumor action is attributable to the interferon system, but it should be pointed out that it has also been shown that interferon preparations exert strong antitumor action when tested against tumors of virus origin (159) , and even against tumors induced by a chemical carcinogen (160) .
